About
ABOUT
- Board Certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine
- Former Associate Professor, Chief of Critical Care Service, and Medical Director of Trauma and Life Support Center at the University of Wisconsin
- President and Chief Medical Officer of the Front Line COVID-19 Critical Care Alliance
- Widely published expert on therapeutic approaches to COVID-19
- Deeply experienced in treatment of COVID-19 in all its phases – prevention, early, late, long-haul, and post-vaccine syndromes
- Pioneer and Senior Editor of a best-selling and award winning textbook, Point of Care Ultrasound
- 1988–1994 B.A. University of Colorado, Boulder, Colorado Major Mathematics
- 1994–1996 M.P.A. New York University, New York, NY Health Policy and Administration
- 1998–2002 M.D. St. George’s University Grenada, West Indies
- 2002–2005 Residency Internal Medicine, Columbia College of Physicians and Surgeons, New York, NY, St. Luke’s–Roosevelt Hospital, New York
- 2005–2008 Fellowship Pulmonary Disease and Critical Care Medicine Albert Einstein College of Medicine, Beth Israel Medical Center, New York
- 2015 Wisconsin Medical License
- 2015 Illinois Medical License
- 2009 Healthcare Simulation Training – Instructor Certification
- 2008, 2019 Pulmonary Diseases
- 2008, 2018 Critical Care Medicine
- 2008 National Board Exam in Echocardiography – Pass
- 2005, 2015 Internal Medicine
AWARDS & HONORS
Trust Benevolent Award-2021
Malaysia – Cheng Ho Multicultural Education Trust Benevolent Award 2021
Appreciation to Humanity-2021
South Africa – SAHARI Foundation Certificate of Appreciation to Humanity 2021
Faculty Excellence in Teaching-2018
Faculty Excellence in Teaching Award, University of Wisconsin Dept. of Medicine 2018
Madison Magazine “Top Docs”-2016-18
Madison Magazine Dane County “Top Docs”- Critical Care 2016-18
.
BMA President’s Choice Award-2015
President’s Choice, British Medical Association Textbook Award 2015
The Center .
Dr. Kory is the founder and lead physician of the Advanced COVID-19 Care Center, a clinic that utilizes remote communication strategies (text, telephone, and video) to conduct illness assessments and develop and prescribe appropriate treatment plans for all phases of COVID-19, including those of the COVID vaccine-injured. He is an internationally renowned and extensively published expert in the prevention and treatment of COVID-19. Dr. Kory has also gained experience through his collaborations with other expert groups in treating those suffering from both “Long Haul COVID” and/or post-COVID-19 vaccine syndromes.
A clinic designed to address people’s individual health needs as they are faced with the challenge of preventing, treating or thriving post-COVID-19 infection or vaccination.
The Provider Team of the Advanced COVID-19 Care Center .
Dr. Kory has trained a team of nurse practitioners and physicians in the use of his protocols. This specialized knowledge allows them to formulate a treatment regimen that best applies to any given patient’s situation. Their treatment protocols include combinations of both FDA-approved and off-label recommended medicines used around the world for all phases and complications of COVID. Each prevention or treatment protocol is created according to each individual patient’s risk factors such as age, co-morbid conditions, severity, co-existing medications, pregnancy status, the phase of illness, and/or suspected variant when presenting. Further, Dr. Kory and his provider team continually adapt the protocols to any rapidly emerging variant and/or trial results of therapeutics by relying on the best and most up-to-date medical evidence along with his daily communications with similar experts in his ever-growing network of committed colleagues around the world.
IVERMECTIN
Dr. Pierre Kory – World-Renowned Expert in the Use of Ivermectin in COVID-19
Value of Ivermectin in Treatment of COVID
Dr. Kory testified in a Senate hearing as long ago as December 2020, that Ivermectin should be systematically deployed as a therapeutic in the prevention and early treatment of COVID worldwide. Since that testimony, 23 countries, (39 when considering non-governmental organizations) have adopted either partial or full use of ivermectin in their guidelines, encompassing 25% of the world’s population. His plea to the U.S government’s medical authorities – the NIH, CDC, and FDA – to urgently review the latest data and then issue guidelines for physicians, nurse practitioners, and physician assistants to prescribe Ivermectin for Covid-19 led to their no longer recommending against use, albeit falling short of a full recommendation for use.
WHAT WE DO
Prevention & Early Treatment Planning Visit
Prepare and obtain medication regimen for chronic …
Acute COVID-19 Treatment Visit
Assessment and formulation of treatment plans tailored to …
Long Haul COVID Visits
Assessment and formulation of treatment plans tailored to …
Post-Vaccine Syndrome Visit
Full assessment and evaluation of the severity, duration, …